You are here

Article Text

Article menu

Download PDFPDF

Therapeutics
Review: oral and intravaginal agents are equally effective for treatment of uncomplicated vulvovaginal candidiasis
Free

http://dx.doi.org/10.1136/ebm.7.4.118

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2001) Cochrane Database Syst Rev 4, CD002845; Watson MC, Grimshaw JM, Bond CM, et al.. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). . . ;(. ):. (latest version 28 May 2001)..

    
 
 QUESTION: Are oral and intravaginal antifungal agents equally effective, safe, and cost effective for uncomplicated vulvovaginal candidiasis?

    Data sources

    Randomised controlled trials (RCTs) published in any language were identified by searching the Cochrane Controlled Trials Register (CENTRAL/CCTR), the Cochrane Collaboration Sexually Transmitted Disease Group Specialised Register of Controlled Trials, EMBASE/Excerpta Medica (1980 to January 2000), and Medline (January 1985 to May 2000). Reference lists of each trial were reviewed, and UK manufacturers of antifungal agents were contacted.

    Study selection

    Trials were selected if they included women ≥ 16 years of age with mycologically confirmed acute vulvovaginal candidiasis (< 4 episodes in 12 mo) and compared ≥ 1 oral antifungal agent with an intravaginal antifungal agent. Trials were excluded if they included only participants who were HIV positive, immunocompromised, pregnant, breast feeding, or diabetic.

    Data extraction

    Data were extracted on the type, dose, frequency, and duration of antifungal treatment; setting; …

    View Full Text